BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11309334)

  • 1. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
    Khuri FR; Wu H; Lee JJ; Kemp BL; Lotan R; Lippman SM; Feng L; Hong WK; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):861-7. PubMed ID: 11309334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.
    Khuri FR; Lotan R; Kemp BL; Lippman SM; Wu H; Feng L; Lee JJ; Cooksley CS; Parr B; Chang E; Walsh GL; Lee JS; Hong WK; Xu XC
    J Clin Oncol; 2000 Aug; 18(15):2798-804. PubMed ID: 10920126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
    Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
    Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium.
    Chang YS; Chung JH; Shin DH; Chung KY; Kim YS; Chang J; Kim SK; Kim SK
    Yonsei Med J; 2004 Jun; 45(3):435-42. PubMed ID: 15227730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer.
    Brattström D; Wester K; Bergqvist M; Hesselius P; Malmström PU; Nordgren H; Wagenius G; Brodin O
    Acta Oncol; 2004; 43(1):80-6. PubMed ID: 15068324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer.
    Brabender J; Park J; Metzger R; Schneider PM; Lord RV; Hölscher AH; Danenberg KD; Danenberg PV
    Ann Surg; 2002 Mar; 235(3):440-3. PubMed ID: 11882767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
    Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
    Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
    Xu XC; Sozzi G; Lee JS; Lee JJ; Pastorino U; Pilotti S; Kurie JM; Hong WK; Lotan R
    J Natl Cancer Inst; 1997 May; 89(9):624-9. PubMed ID: 9150186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer.
    Kim HS; Youm HR; Lee JS; Min KW; Chung JH; Park CS
    Lung Cancer; 2003 Nov; 42(2):163-70. PubMed ID: 14568683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer.
    Gridelli C; Maione P; Airoma G; Rossi A
    Curr Med Chem; 2002 Nov; 9(21):1851-8. PubMed ID: 12369871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
    Ermert L; Dierkes C; Ermert M
    Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the prostaglandin biosynthetic pathway in non-small cell lung cancer: a comparison with small cell lung cancer and correlation with angiogenesis, angiogenic factors and metastases.
    Yoshimoto A; Kasahara K; Kawashima A; Fujimura M; Nakao S
    Oncol Rep; 2005 Jun; 13(6):1049-57. PubMed ID: 15870920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer.
    Laga AC; Zander DS; Cagle PT
    Arch Pathol Lab Med; 2005 Sep; 129(9):1113-7. PubMed ID: 16119982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
    Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
    Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.
    Niki T; Kohno T; Iba S; Moriya Y; Takahashi Y; Saito M; Maeshima A; Yamada T; Matsuno Y; Fukayama M; Yokota J; Hirohashi S
    Am J Pathol; 2002 Mar; 160(3):1129-41. PubMed ID: 11891209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: analyses of tumor heterogenity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-alpha (GST)-alpha, GST-mu, and GST-pi.
    Mathieu A; Remmelink M; D'Haene N; Penant S; Gaussin JF; Van Ginckel R; Darro F; Kiss R; Salmon I
    Cancer; 2004 Oct; 101(8):1908-18. PubMed ID: 15386340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma.
    Gallo O; Masini E; Bianchi B; Bruschini L; Paglierani M; Franchi A
    Hum Pathol; 2002 Jul; 33(7):708-14. PubMed ID: 12196922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.
    Dohadwala M; Luo J; Zhu L; Lin Y; Dougherty GJ; Sharma S; Huang M; Pold M; Batra RK; Dubinett SM
    J Biol Chem; 2001 Jun; 276(24):20809-12. PubMed ID: 11320076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.